Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Probiodrug and Crossbeta Biosciences extend their strategic partnership in the field of Alzheimer’s disease biomarkers
December 5, 2017 Off

Probiodrug and Crossbeta Biosciences extend their strategic partnership in the field of Alzheimer’s disease biomarkers

By Dino Mustafić

Probiodrug, a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer’s disease (AD), and the Dutch biotech company Crossbeta Biosciences have extended their strategic…

BioPharma Credit, and BioPharma Credit Invesments lend $200 million to Lexicon
December 5, 2017 Off

BioPharma Credit, and BioPharma Credit Invesments lend $200 million to Lexicon

By Dino Mustafić

BioPharma Credit and BioPharma Credit Investments IV, a private fund that also invests in life sciences debt, have said they…

Arix Bioscience puts $8 million for a stake in Atox Bio, gets a place in Board of Directors
December 4, 2017 Off

Arix Bioscience puts $8 million for a stake in Atox Bio, gets a place in Board of Directors

By Dino Mustafić

Arix Bioscience has led an oversubscribed $30 million Series F financing round for a clinical biotechnology company Atox Bio.

Idorsia welcomes $230 million milestone for Janssen’s agreement opt-in decision
December 4, 2017 Off

Idorsia welcomes $230 million milestone for Janssen’s agreement opt-in decision

By Dino Mustafić

Idorsia said Monday Janssen Biotech, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has exercised its option to enter…

Keeping Healthy If You Are Unemployed
December 4, 2017 Off

Keeping Healthy If You Are Unemployed

By Dino Mustafić

If you are unemployed, keeping fit and healthy should be a priority. Exercise releases serotonin in the brain, helping you…

December 4, 2017 Off

Sanofi’s Toujeo neet main objective in head-to-head study versus insulin degludec

By Dino Mustafić

Sanofi’s Toujeo met the primary study objective in the first large head-to-head clinical trial, called BRIGHT study, comparing Toujeo with insulin…

XBiotech with potential breakthrough for treatment of HS with MABp1, study suggests
December 4, 2017 Off

XBiotech with potential breakthrough for treatment of HS with MABp1, study suggests

By Dino Mustafić

Texas-headquartered biosciences company XBiotech announced Monday the publication of data from its randomized phase 2 study in which it tested…

December 1, 2017 Off

Faron welcomes new Chief Commercial Officer from AstraZeneca

By Dino Mustafić

Faron Pharmaceuticals has appointed Dr. Juhana Heinonen as Chief Commercial Officer to join the company in January 2018.

Destiny Pharma, China’s CMS Medical Venture ink deal for dealing with Destiny’s drug candidates in Asian region
December 1, 2017 Off

Destiny Pharma, China’s CMS Medical Venture ink deal for dealing with Destiny’s drug candidates in Asian region

By Dino Mustafić

Destiny Pharma said on Friday that its development and commercialisation collaboration agreement with CMS Medical Venture Investment Limited, a wholly…

December 1, 2017 Off

Basila, Pfizer extend deal for several regions for Basilea’s Cresemba, adds China and 16 countries in Asia Pacific

By Dino Mustafić

Basilea Pharmaceutica International has amended its existing license agreement for Europe, Russia, Turkey and Israel with Pfizer Inc. for Basilea’s…

Posts pagination

Previous 1 … 3,422 3,423 3,424 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine